Bococizumab
CAS: 1407495-02-6
Ref. TM-T76739
| 1mg | 324.00 € | ||
| 5mg | 810.00 € | ||
| 10mg | 1,290.00 € | ||
| 25mg | 1,838.00 € | ||
| 50mg | 2,581.00 € | ||
| 100mg | 3,483.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Product Information
Name:
Bococizumab
Synonyms:
- RN316
- PF-04950615
Description:
Bococizumab (PF-04950615) is a humanized mAb that inhibits PCSK9, reducing blood LDL cholesterol to treat hypercholesterolemia.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
145.0 kDa
Purity:
SDS-PAGE:97.2%;SEC-HPLC:97.7%
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76739 Bococizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
